Icecure Medical is trading 13.01% down now at $3.05 after Q2 results missed expectations.
- Q2 EPS was -$3.11 versus a -$1.53 estimate; revenue reached $910,000 versus $1.48 million expected.
- First-half revenue rose approximately 45% year over year to $1.8 million, supported by systems and disposable probes.